1-3 of 3
Alexandra M. Stevens
Close
Sort by
Journal Articles

Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency

Monika W. Perez, Oscar Sias-Garcia, Alfred Daramola, Helen Wei, Maci Terrell, Raushan Rashid, Woojun D. Park, Kevin Duong, Terzah M. Horton, Feng Li, Nikitha Cherayil, Jost Vrabic Koren, Vincent U. Gant, Jacob J. Junco, Choladda V. Curry, Alexandra M. Stevens, Charles Y. Lin, Joanna S. Yi
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4864–4876.
https://doi.org/10.1182/bloodadvances.2020003737
Published: 2021
Includes: Supplemental data
Journal Articles

Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation

Alexandra M. Stevens, Michael Xiang, Lisa N. Heppler, Isidora Tošić, Kevin Jiang, Jaime O. Munoz, Amos S. Gaikwad, Terzah M. Horton, Xin Long, Padmini Narayanan, Elizabeth L. Seashore, Maci C. Terrell, Raushan Rashid, Michael J. Krueger, Alicia E. Mangubat-Medina, Zachary T. Ball, Pavel Sumazin, Sarah R. Walker, Yoshimasa Hamada, Seiichi Oyadomari, Michele S. Redell, David A. Frank
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4215–4227.
https://doi.org/10.1182/bloodadvances.2019000499
Published: 2019
Includes: Supplemental data
Journal Articles

Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance

Clinical Trials & Observations
Alexandra M. Stevens, Jennifer M. Miller, Jaime O. Munoz, Amos S. Gaikwad, Michele S. Redell
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1387–1397.
https://doi.org/10.1182/bloodadvances.2017007856
Published: 2017
Includes: Supplemental data